Article Text

PDF

Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia.
  1. R L Rodwell,
  2. P H Gray,
  3. K M Taylor,
  4. R Minchinton
  1. Division of Haematology, Mater Misericordiae Hospitals, South Brisbane 4101, Australia.

    Abstract

    Granulocyte colony stimulating factor (G-CSF) treatment was successfully used in three preterm infants with alloimmune neonatal neutropenia (AINN). Two infants had persistent neutropenia despite treatment with intravenous immunoglobulin and random donor granulocyte transfusions for presumed sepsis. Neutrophil counts returned to normal with G-CSF treatment; the response was least convincing in one infant with fulminant necrotising enterocolits. It is suggested that treatment with G-CSF be considered early for the treatment of infants with AINN.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.